Inventiva S.A. Files 2025 Annual Report

Ticker: IVA · Form: 20-F · Filed: 2026-04-08T09:01:57-04:00

Sentiment: neutral

Topics: annual-report, 20-F, financials

TL;DR

Inventiva dropped its 2025 20-F. Check financials.

AI Summary

Inventiva S.A. filed its annual report on Form 20-F for the fiscal year ending December 31, 2025. The filing, accepted on April 8, 2026, includes various exhibits such as the main 20-F document, financial statements, and other disclosures. The company's principal executive offices are located at 50 Rue de Dijon, Daix, France.

Why It Matters

This filing provides investors and stakeholders with a comprehensive overview of Inventiva S.A.'s financial performance and business operations for the 2025 fiscal year, crucial for assessing the company's health and future prospects.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, Inventiva is subject to inherent risks related to drug development, regulatory approvals, and market competition, which are detailed within the 20-F filing.

Key Numbers

7687242 — 20-F iXBRL Size (Indicates the size of the primary financial document in bytes.)
34851449 — Complete Submission Text File Size (Represents the total size of the submission in bytes.)

Key Players & Entities

Inventiva S.A. (company) — Filer of the 20-F report
0001756594 (company) — CIK number for Inventiva S.A.
2026-04-08 (date) — Filing date of the 20-F
2025-12-31 (date) — Period of report for the 20-F
50 RUE DE DIJON DAIX I0 21121 (location) — Mailing and Business Address of Inventiva S.A.

FAQ

What is the primary purpose of the Form 20-F filing?

The Form 20-F is an annual report required for foreign private issuers, providing comprehensive financial and business information for the fiscal year.

When was Inventiva S.A.'s 2025 annual report filed and accepted?

The filing date and acceptance date for Inventiva S.A.'s 2025 Form 20-F was April 8, 2026.

What is the fiscal year end for Inventiva S.A. as reported in this filing?

The fiscal year end for Inventiva S.A. is December 31, 2025.

Where are Inventiva S.A.'s principal executive offices located?

Inventiva S.A.'s principal executive offices are located at 50 Rue de Dijon, Daix, France.

What are some of the key exhibits included in this 20-F filing?

The filing includes the main 20-F document (iva-20251231x20f.htm), exhibits such as EX-1.1, EX-2.4, EX-4.3, EX-4.4, EX-11.1, EX-12.1, EX-12.2, EX-13.1, EX-15.1, and various XBRL data files.

From the Filing

EDGAR Filing Documents for 0001104659-26-040704 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: SEC Accession No. 0001104659-26-040704 Filing Date 2026-04-08 Accepted 2026-04-08 09:01:57 Documents 171 Period of Report 2025-12-31 Interactive Data Document Format Files Seq Description Document Type Size 1 20-F iva-20251231x20f.htm iXBRL 20-F 7687242 2 EXHIBIT 1.1 iva-20251231xex1d1.htm EX-1.1 102253 3 EXHIBIT 2.4 iva-20251231xex2d4.htm EX-2.4 230973 4 EXHIBIT 4.3 iva-20251231xex4d3.htm EX-4.3 29035 5 EXHIBIT 4.4 iva-20251231xex4d4.htm EX-4.4 31355 6 EXHIBIT 11.1 iva-20251231xex11d1.htm EX-11.1 60000 7 EXHIBIT 12.1 iva-20251231xex12d1.htm EX-12.1 8823 8 EXHIBIT 12.2 iva-20251231xex12d2.htm EX-12.2 7967 9 EXHIBIT 13.1 iva-20251231xex13d1.htm EX-13.1 5698 10 EXHIBIT 15.1 iva-20251231xex15d1.htm EX-15.1 3149 11 GRAPHIC iva-20251231x20f005.jpg GRAPHIC 8917 Complete submission text file 0001104659-26-040704.txt 34851449 Data Files Seq Description Document Type Size 12 EX-101.SCH iva-20251231.xsd EX-101.SCH 218952 13 EX-101.CAL iva-20251231_cal.xml EX-101.CAL 103772 14 EX-101.DEF iva-20251231_def.xml EX-101.DEF 822148 15 EX-101.LAB iva-20251231_lab.xml EX-101.LAB 1241173 16 EX-101.PRE iva-20251231_pre.xml EX-101.PRE 1226588 175 EXTRACTED XBRL INSTANCE DOCUMENT iva-20251231x20f_htm.xml XML 9060107 Mailing Address 50 RUE DE DIJON DAIX I0 21121 Business Address 50 RUE DE DIJON DAIX I0 21121 33380447500 Inventiva S.A. (Filer) CIK : 0001756594 (see all company filings) EIN. : 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231 Type: 20-F | Act: 34 | File No.: 001-39374 | Film No.: 26846655 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)